* Retail distribution agreement for Nordics and UK with Norgesgruppen * Successfull private offering on NOK 55 securing a good cash position to see company through to positive cash flow * Enthustiastic Danish coverage of successfull animal experiments for antiviral inhalation treatment "Possible game changer, says University of Copenhagen"
Comes on top of previous news that the company received a 2 milln USD grant from the United States defence for their wound treatment product
Note
Softox trading above earlier triangle formation, stay in trade.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.